Drug intelligence / Profile preview

EnovNutributter+

Development stage: Preclinical
Lead developer: Nutriset
Administration: Oral

Overview

EnovNutributter+ is a nutritional supplement and medical nutrition product developed by Laboratorio Pablo Cassara. It is categorized as a therapeutic food or lipid-based nutrient supplement (LNS) intended to address malnutrition and specific nutritional deficiencies. The product is designed for oral administration and provides a concentrated source of essential vitamins, minerals, and macronutrients to support health and development in individuals with inadequate dietary intake, particularly in vulnerable populations such as children. It is part of the company's portfolio of specialized treatments and nutritional products.

Brand names: EnovNutributter+
Other names: EnovNutributter

Beyond the preview

Go deeper on EnovNutributter+.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EnovNutributter+.

Explore the full profile